Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-22

Clinical Trial Update: Identification and Validation of Epigenetic Biomarkers of PMDD

View source ↗

Summary

A clinical trial update on identifying and validating epigenetic biomarkers for Premenstrual Dysphoric Disorder (PMDD), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: PMDD, Premenstrual Dysphoric Disorder (PMDD) | Status: RECRUITING